Virpax Pharmaceuticals Stock (NASDAQ:VRPX), Quotes and News Summary

Q: What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 24.101K
Day Range	- - -
52 Wk Range	2.402 - 11.774
Market Cap	$5.153M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	3.43%
Days to Cover	1.08

Recent News

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.

Avi Kapoor

Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.

Avi Kapoor

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Virpax Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Virpax Pharmaceuticals (VRPX) stock?

You can purchase shares of Virpax Pharmaceuticals (NASDAQ: VRPX) through any online brokerage.

View our list of the best stock brokerages.

Who are Virpax Pharmaceuticals's (VRPX) competitors?

Other companies in Virpax Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).

What is the target price for Virpax Pharmaceuticals (VRPX) stock?

The latest price target for Virpax Pharmaceuticals (NASDAQ: VRPX) was reported by Maxim Group on Thursday, June 9, 2022. The analyst firm set a price target for 4.00 expecting VRPX to fall to within 12 months (a possible -9.09% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Virpax Pharmaceuticals (VRPX)?

The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $4.4 last updated April 18, 2024 at 4:37 PM EDT.

Does Virpax Pharmaceuticals (VRPX) pay a dividend?

There are no upcoming dividends for Virpax Pharmaceuticals.

When is Virpax Pharmaceuticals (NASDAQ:VRPX) reporting earnings?

Virpax Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Virpax Pharmaceuticals (VRPX) going to split?

There is no upcoming split for Virpax Pharmaceuticals.

What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-